JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
Stocks Crossing 50-Day SMA 05/07: (PFE) (JPM) (ARNA) Above; (FTR) (GGB) (ORCL) Below
-
StreetInsider.com Pre-Open Movers 5/3: (PKT) (YRCW) (WTW) Higher; (DCTH) (VCRA) (LNKD) Lower (more...)
-
Notable Analyst Rating Changes 02/06: (MHP) (GCI) (AGN) Upgraded; (SIRI) (TRMB) (HOLX) Downgraded
-
Arena (ARNA) Chugs Higher on Volume; Will Present at JP Morgan Conf. Tomorrow
-
Streetinsider.com's Hot Lunchtime Reads 12/21: (AAPL) (OREX) (PNK) (RIMM)
-
JPMorgan Confident Orexigen's (OREX) Will Receive FDA Approval; Comments on Meeting
-
Notable Analyst Rating Changes 09/06: (AKS) (ATVI) (GOLD) Upgraded; (NOK) (CLF) (OCZ) Downgraded
-
Orexigen (OREX) Higher Again, Shares Now Up ~90% in June Following Arena (ARNA), Analyst Upgrade
-
UPDATE: JPMorgan Upgrades Orexigen Therapeutics (OREX) to Overweight, Best Opportunity in Obesity Space
-
JPMorgan Boosts Target on Vivus (VVUS), More Confidence in Approval
-
JPMorgan Muted on Arena Pharma (ARNA) After Approval, Lifts Target to $11
-
Orexigen (OREX) Pops Higher on Analyst Upgrade; Volatility Up
-
Arena Pharmaceuticals (ARNA) is Getting Closer and Closer to the Green Light
-
Streetinsider.com's Hot Lunchtime Reads 05/11: (JPM) (ARNA) (KSS) (INTC) (HOG) (VVUS)
-
Pre-Open Movers 5/11: (ARNA) (LEAP) (MDR) Higher; (JPM) (MCP) (C) Lower (more...)
-
After-Hours Movers 05/10: (ARNA) (OREX) (AVG) Higher; (PEIX) (DAR) (PBTH) (ASYS) (JPM) Lower
-
Market Wrap: Dow Snaps Streak; Initial Claims See Downside; JPMorgan Dips on 'Sloppy' Risk Management
-
Morning Movers 01/28: CHMP, TMRK, OPLK, BGP, TNAV, ARAY, SVVS, ARBA, EPAY Higher; AEN, MWW, BNVI, INFN, TSRA, ARNA Lower
-
Notable Analyst Rating Changes 09/09: AUO, LYG, INFN, NTAP Upgraded; SEH, SLAB, MPEL, ARNA Downgraded
-
Notable Analyst Rating Changes 08/04: LEAP, BKS, MET, SQNM Upgraded; BHI, DOW, AEP, ARNA Downgraded
-
Notable Analyst Rating Changes 08/02: KO, MJN, IBN, CVH Upgraded; ARNA, MU, LLTC, BPO Downgraded
-
JP Morgan Downgrades Arena Pharmaceuticals (ARNA) to Neutral
-
Notable 52-Week High's and Low's of the Day 07/30: PWER, ARNA, SATC, TEN High; WFR, TNAV, BIOS, NVDA Low
-
Unusual 11 Mid-Day Movers 07/16: LSBX, ARNA, AVII, CYPB, SCHW, TSLA Higher; VVUS, JST, ROIAK, OREX, PLCM Lower
-
Notable Analyst Rating Changes 07/16: GS, JPM, ARNA, ADM Upgraded; VVUS, BP, RBA, OREX Downgraded
-
Morning Movers 7/16: LSBX, ARNA, AVII Higher; VVUS, JST, VRNM, BIOF, VIDE, PLCM Lower
-
Arena Pharmaceuticals (ARNA) 17% Higher Following Vivus's Qnexa Blow-up
-
Arena Pharmaceuticals (ARNA): Upgraded to Overweight at J.P. Morgan
-
J.P. Morgan on Biotechnology and Drugs Stocks; Upgrades ARNA, Cuts VVUS
-
Notable Analyst Rating Changes 07/02: BJ, ARNA, NI, CEDC Upgraded; GRMN, SWN, EQR Downgraded
-
Notable Analyst Rating Changes 12/17: NWSA, UNM, LNC, PTV Upgraded; ADP, AEM, FGXI, OC Downgrades
-
Unusual 11 Mid-Day Movers 3/30: PRSC, FAZ, SPRD, FXP Higher; LNC, ARNA, MTW, TRW Lower
